An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
Clinical trial NCT00880061 · TERMINATED
Trial details
- NCT number
- NCT00880061
- Sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-07
- Primary completion
- 2015-06-05
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.